Skip to content

Comprehensive AI-Integrated Palliative Healthcare Management System for Cancer Patients Across the Continuum of Care

Comprehensive AI-Integrated Palliative Healthcare Management System for Cancer Patients Across the Continuum of Care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099116
Enrollment
Unknown
Registered
2025-03-18
Start date
2025-03-18
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer pain

Interventions

Intervention group I:Starting from the first month, patients received integrated early palliative care (EPC) alongside standard anti-tumor therapy. The EPC protocol included: 1.Regular EPC team consul
2.Comprehensive symptom and psychosocial assessments
3.24/7 telephone crisis support
4.Home care evaluation with community service coordination
5.Transition to home-based palliative care when ECOG >=3 or patient-requested
6.Dedicated inpatient palliative beds for urgent care.
Intervention group II:Starting from the second month, patients received integrated early palliative care (EPC) alongside standard anti-tumor therapy. The EPC protocol included: 1.Regular EPC team cons
Intervention group III:Starting from the third month, patients received integrated early palliative care (EPC) alongside standard anti-tumor therapy. The EPC protocol included: 1.Regular EPC team cons
5.Transition to home-based palliative care when ECOG >=3 or patient-requested
Intervention group IV:Starting from the fourth month, patients received integrated early palliative care (EPC) alongside standard anti-tumor therapy. The EPC protocol included: 1.Regular EPC team cons

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 80 years; ECOG (Eastern Cooperative Oncology Group) Performance Status score 0-2; Capable of completing the Revised Edmonton Symptom Assessment System (ESAS-r);Primary tumor deemed unsuitable for curative surgical resection; Oncologist-estimated survival prognosis of 6-36 months.

Exclusion criteria

Exclusion criteria: Inability to complete questionnaire assessments; Significant cognitive impairment (score 10 errors).

Design outcomes

Primary

MeasureTime frame
Functional Assessment of Cancer Therapy – General ;

Secondary

MeasureTime frame
Health-Related Quality of Life ;Treatment Satisfaction;

Countries

China

Contacts

Public ContactCang Jing

Zhongshan Hospital, Fudan University

cangjing_zs@sina.com+86 139 1601 0421

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026